These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8909102)
21. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. Ballinger JR; Kee JW; Rauth AM J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295 [TBL] [Abstract][Full Text] [Related]
22. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice. Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139 [TBL] [Abstract][Full Text] [Related]
23. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia. Rasey JS; Hofstrand PD; Chin LK; Tewson TJ J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326 [TBL] [Abstract][Full Text] [Related]
25. 99mTc demotate 1: biodistribution and elimination characteristics in rats. Kopecky M; Trejtnar F; Laznicek M; Laznickova A; Semecky V; Maina T; Nock B Nucl Med Commun; 2005 Jun; 26(6):549-54. PubMed ID: 15891599 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, tissue distribution and tumor uptake of 99mTc- and 67Ga-tetrasulfophthalocyanine. Rousseau J; Ali H; Lamoureux G; Lebel E; van Lier JE Int J Appl Radiat Isot; 1985 Sep; 36(9):709-16. PubMed ID: 4066065 [TBL] [Abstract][Full Text] [Related]
27. Tumour hypoxia and technetium tracers: in vivo studies. Abrantes AM; Serra E; Goncalves C; Oliveiros B; Laranjo M; Sarmento-Ribeiro AB; Rocha-Gonsalves A; Botelho MF Curr Radiopharm; 2012 Apr; 5(2):99-105. PubMed ID: 22280110 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of 99mTc-labelled vitamin K4 as an agent for testicular imaging. Ercan MT; Durak HS; Kitapçi M; Caner BE; Senekowitsch R Nuklearmedizin; 1991 Feb; 30(1):35-9. PubMed ID: 2062675 [TBL] [Abstract][Full Text] [Related]
29. BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors. Melo T; Duncan J; Ballinger JR; Rauth AM J Nucl Med; 2000 Jan; 41(1):169-76. PubMed ID: 10647620 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, biodistribution and quantitative structure-activity relationship studies of new 99mTc labeled pseudo-peptide complexes. Zhang H; Dai M; Qi C; Li B; Guo X Appl Radiat Isot; 2004 May; 60(5):643-51. PubMed ID: 15082041 [TBL] [Abstract][Full Text] [Related]
31. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD. Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303 [TBL] [Abstract][Full Text] [Related]
34. Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology. Giglio J; Rey A; Cerecetto H; Pirmettis I; Papadopoulos M; León E; Monge A; López de Ceráin A; Azqueta A; González M; Fernández M; Paolino A; León A Eur J Med Chem; 2006 Oct; 41(10):1144-52. PubMed ID: 16782237 [TBL] [Abstract][Full Text] [Related]
35. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. Ballinger JR; Hsue V; Rauth AM Nucl Med Commun; 2003 May; 24(5):597-606. PubMed ID: 12717079 [TBL] [Abstract][Full Text] [Related]
36. Biodistribution of two (131)I-IMBA preparations, differently labelled, in mice with experimental B16 melanoma tumours. Janczak M; Kapuściński J; Olasik EM; Rózalski M; Płachcińska A; Kuśmierek J Nucl Med Rev Cent East Eur; 2008; 11(2):48-52. PubMed ID: 19585454 [TBL] [Abstract][Full Text] [Related]
37. Preparation of 99mTc-ethylene dicysteine (99mTc-EC) by transchelation using 99mTc-glucoheptonate (99mTc-GHA) and its evaluation for renal function studies. Vanaja R; Solav SV; Joshi SH; Kumar P; Ramamoorthy N Nucl Med Commun; 2000 Oct; 21(10):977-82. PubMed ID: 11130341 [TBL] [Abstract][Full Text] [Related]
39. Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents. Vanbilloen HP; Bormans GM; De Roo MJ; Verbruggen AM Nucl Med Biol; 1995 Apr; 22(3):325-38. PubMed ID: 7627148 [TBL] [Abstract][Full Text] [Related]
40. Towards developing a non-SnCl2 formulation for RP444, a new radiopharmaceutical for thrombus imaging. Liu S; Edwards DS; Harris AR; Ziegler MC; Poirier MJ; Ewels BA; Diluzio WR; Hui P J Pharm Sci; 2001 Feb; 90(2):114-23. PubMed ID: 11169528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]